This investigation was undertaken to evaluate the functional contribution of the peptide backbone of oxytocin in its interaction with receptor. CoreyPauling-Koltun models of [Gly7]deaminooxytocin, de-aminotocinamide, and their respective retro-D-analogs built in any specific conformation (e.g., the Walter-Urry model for oxytocin) have a quasi-equivalent topochemical arrangement of amino-acid side chains; however, the CO and NH elements of the peptide backbone of the retro-Danalog are reversed. The retro-D-analogs of deaminotocinamide and [Gly7jdeaminooxytocin (prepared using D-alle for L-Ile) and their respective N-formyl derivatives were assayed for uterotonic activity relative to related L-peptides. All retro-D-analogs (tested at concentrations ranging from 10-10 to 1O-5 M) were devoid of agonistic (or antagonistic) activity in the isolated rat uterus, except for the retro-D-[D-alle3, Gly7jdeaminooxytocinamine, which retains a terminal NH2 group on the tail; the latter is a partial agonist with very low affinity. The results obtained with retro-D-analogs indicate that one or more of the elements of the peptide backbone of the tocinamide ring are essential for "occupation" and "activation" of uterine receptors. Oxytocin action may be the resultant of multiple hydrogen-bonding interactions between CO, NH, NH2, and OH groups of the hormone with complementary groups on receptor, made possible by appropriate hydrophobic bonding.
The distinctive topological arrangement of amino-acid side chains of a peptide hormone at the receptor surface is believed to be the primary determinant for those interactions that establish "occupancy" and "activation" of receptors (1) . The contribution of the peptide backbone has received little attention. The fact that retro-D-analogs (2) * of certain cyclic pep- tides have similar biological activities as those exhibited by the parent compound (3) (4) (5) is consistent with the idea that the peptide backbone serves only as a structural scaffold for projecting amino acid side chain functionalities.t In a retro-Danalog, the "overall shape" and topochemical pattern of side chains are "quasi-equivalent" to that of a normal peptide (provided that Pro is not part of the sequence) (2) (3) (4) , and differs from the normal peptide in that the CO and NH elements of the peptide bonds, as well as the amino and carboxyl termini, are reversed.
If the amide elements of the backbone do not serve an important functional role in hormone action, appropriate Abbreviation: MEA, #-mercaptoethylamine.
* A retro-D-peptide is a peptide chain built Of D-amino acids bonded in reverse sequence as the ipeptide. Holton (10) as modified by AMunsick (11) , with uteri from castrated rats that had been treated with estrogen. The peptide dose that produced half-maximal response (designated as apparent Ka) was determined for each analog relative to a synthetic standard preparation of oxytocin with potency of 510 U/mg in the avian vasodepressor assay § (12) . The uterotonic activity of each analog is the result of assaying isolated uteri from at least four different rats.
t Shemyakin et al. (3) reported that N-acetyl-Leu-Tyr-NHCH3 was a substrate for pepsin, whereas acetyl-D-Tyr-D-Leu-NHCH3 (the retro-D-analog of the LL dipeptide) behaved as competitive inhibitor, and that both peptides showed a similar inhibition constant, Ki, for the inhibition of p-nitrophenyl pivalate hydrolysis by chymotrypsin. This finding also supports the expectation that retro-D-peptides would be less susceptible to the degradative enzymes present in mammalian systems, which normally operate selectively on peptides built of i~amino acids. § We acknowledge the kind collaboration of D)r. R. Walter for his evaluation of our synthetic oxytocin standard in the avian vasodepressor assay. Our synthetic oxytocin has the same activity (510 U/mg) in the avian depressor assay as the oxytocin standard of D)r. Walter (30) . 563 ine, inasmuch as the cysteine residue has a free amino group. I was purified by gel filtration (18) , partition chromatography on Sephadex G-25 (19) , or silica gel adsorption chromatography. Purified I was homogeneous on thin-layer chromatography with silica gel plates, paper chromatography, and paper electrophoresis; it had correct elemental analysis and showed the expected amino acid molar ratios.
N-Fornmylation of I with p-nitrophenyl formate (For-ONp) led to II, which was homogeneous on silica gel thin-layer chromatography and paper chromatography and showed the expected lack of mobility on paper electrophoresis.
For the synthesis of retro-D-[D-alle3, Gly7]deaminooxytocin (III), Gly-OMe -HCl was coupled with Z-D-Leu-ONp, yielding Z-D-Leu-Gly-OMe. The latter was deprotected by hydrogenation and the aminopeptide ester was coupled with Boc-Gly-ONp, yielding Boc-Gly-D-Leu-Gly-OMe, which in turn afforded the protected tripeptide acid after saponification. Activation of Boc-Gly-D-Leu-Gly by the mixed anhydride method followed by coupling with I, gave a protected octapeptide, which, after removal of the Boc-group in 25% trifluoroacetic acid-CH2Cl2 and purification on Sephadex G-25, yielded III. Formylation of III with For-ONp gave N-formylretro-D-[D-aIle3, Gly7]deaminooxytocinamide (IV).
Analogs III and IV were purified and analyzed by the general techniques described for I and II.
RESULTS
The oxytocin analogs used as standards for retro-D-compounds all evoked maximal uterotonic response and differed in apparent affinity, as expressed in differences in Ka (Table I) Peptide hormone action involves a transaction where information conveyed by the hormone molecule is received and transduced by the receptor of the target cell into a biophysical or biochemical "signal" which activates the next element in a system leading to biological response (20) . The process involves a "pattern recognition" reaction where the relatively flexible hormone assumes (if it does not already possess) adistinctive "active" conformation at the surface of the receptor. This hormone conformation is the consequence of a series of binary interactions between specific chemical groups of the hormone with complementary groups of the receptor, the totality of these interactions resulting in "specific binding." The receptor-hormone complex thus formed is generally considered to initiate "action" via a conformational change in the receptor element. Of the interactions of functional groups of the hormone, it has been widely assumed that some are directly related and intimately involved in the informational transduction process, whereas others serve to "fit" the hormone molecule to the receptor surface. The latter set of groups of the hormone molecule are generally designated as "binding" or "attachment" sites and differentiated from the first set, ¶ This was the highest concentration that could be tested with the limited amounts available to us. Two alternative models of the oxytocin receptor "pocket" may be envisaged, depending whether the amide elements of the backbone postulated to be critical for receptor activation, are present on one (Fig. la) or both surfaces (Fig. lb) of the peptide ring. In either case, transduction would involve a series of cooperative interactions involving both hydrophobic and hydrogen bonding. In Fig. la, hydrogen bonding between the nonplanar surface of the peptide and the receptor surface would proceed in a hydrophobic environment, the planar surface with the backbone lle3-CO group being exposed to the aqueous environment. The alternative model postulates that both surfaces of the peptide molecule interact with the surfaces of the receptor pocket (Fig. lb) . In the latter model, the nonplanar surface with projecting amino-acid side chains would provide distinctive features for specific "recognition," while the planar surface and the edges of the ring would have a topochemical pattern of backbone CO groups at the receptor site which might be a general feature required for transduction in peptide hormone action.
The present results are consistent with a previous proposal (27) Note Added in Proof. Retro-D-[D-aIle3, Gly7, malonamide9]-deaminooxytocin, a derivative where the "tail" has a carboxamide terminus similar to glycinamide in oxytocin, has now been synthesized and likewise is without biological activity (at 10-M) in the uterotonic assay. Thus, the negative results with the retro-D-analogs of [Gly7]deaminooxytocin reported here are not due to a special role of the carboxamide function present on oxytocin.
